Register

Aclarion Announces Closing of $3.0 Million Public Offering

Retrieved on: 
Tuesday, February 27, 2024
Algorithm, Prospectus, ACON, Register, Physician, Sale, Form, Biomarker, CO, Security (finance)

Each unit was sold at a public offering price of $0.58.

Key Points: 
  • Each unit was sold at a public offering price of $0.58.
  • The common warrants are immediately exercisable at a price of $0.58 per share and expire five years from the date of issuance.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, are approximately $3.0 million.
  • The offering was made only by means of a prospectus which is a part of the Registration Statement.

MAPLEBEAR INC. (NASDAQ: CART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Maplebear Inc. d/b/a Instacart

Retrieved on: 
Monday, February 26, 2024
Court, Prospectus, Register, Action Replay, News, Advertising, District court, Complaint, Form, Food, IPO, Defendant, Environment, Security (finance)

If you purchased or acquired Instacart securities, including pursuant to the IPO, and/or would like to discuss your legal rights and options please visit Maplebear Inc.

Key Points: 
  • If you purchased or acquired Instacart securities, including pursuant to the IPO, and/or would like to discuss your legal rights and options please visit Maplebear Inc.
  • If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2024.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

MSS FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action – MSS

Retrieved on: 
Monday, February 26, 2024
Titan, Court, Prospectus, Register, Advertising, EB-5, Supermarket

WHAT TO DO NEXT: To join the Maison Solutions class action, go to https://rosenlegal.com/submit-form/?case_id=21393 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Maison Solutions class action, go to https://rosenlegal.com/submit-form/?case_id=21393 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

MSS NEWS: Johnson Fistel Notifies Maison Solutions Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline

Retrieved on: 
Monday, February 26, 2024
Complaint, SAN, Court, Register, Action Replay, EB-5, Supermarket, LLP

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Maison Solutions Inc. (NASDAQ: MSS).

Key Points: 
  • SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Maison Solutions Inc. (NASDAQ: MSS).
  • The class action is on behalf of shareholders who purchased or otherwise acquired Maison Solutions in or traceable to Maison Solutions October 2023 initial public offering (the “IPO”).
  • What can Investors Do: Shareholders who incurred losses during the class period, have until March 4, 2024, to move the court to become a lead plaintiff in this action.
  • An investor's ability to share any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff.

Aclarion Announces Pricing of $3.0 Million Public Offering

Retrieved on: 
Monday, February 26, 2024
Algorithm, Prospectus, ACON, Register, Physician, Sale, Form, Biomarker, CO, Security (finance)

Each unit is being sold at a public offering price of $0.58.

Key Points: 
  • Each unit is being sold at a public offering price of $0.58.
  • The common warrants will be immediately exercisable at a price of $0.58 per share and will expire five years from the date of issuance.
  • Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $3.0 million.
  • The offering is being made only by means of a prospectus which is a part of the Registration Statement.

VoIP Testing with SIP Emulation and Conformance Test Suite

Retrieved on: 
Monday, February 26, 2024
Phonation, ISUP, C'mon You Know, UAC, Command-line interface, Air traffic control, Register, ETSI, Equipment, Interactive voice response, UAS, FAX, Java, EUROCAE, Air navigation service provider, Emergency service, Instant, Human, Python, IVR, RTP, Instant messaging, SIP, DTMF, Session Initiation Protocol, Voice over IP, IP, Agent handling, Telecommunications, MSRP, ADHD (Joyner Lucas album), Telecom, Software, CPS, Mobile phone

Vijay Kulkarni, CEO of GL Communications, highlights the software's capabilities, stating, “ MAPS™ SIP is a complete VoIP emulation solution.

Key Points: 
  • Vijay Kulkarni, CEO of GL Communications, highlights the software's capabilities, stating, “ MAPS™ SIP is a complete VoIP emulation solution.
  • SIP Protocol Conformance Testing: GL's SIP testing tool boasts proficiency in emulating diverse interfaces within SIP networks, encompassing standard SIP, SIP-I (ISUP) , SIP IMS , and SIP MSRP.
  • Furthermore, it executes SIP Protocol Conformance Testing for varied SIP protocol implementations crucial to the Next Generation Air Traffic Control System , such as ED-137 compliance.
  • MAPS™ SIP Conformance Suite offers 400+ test cases aligned with ETSI TS 102 027-2 V3.1.1 (2004-11) SIP specifications.

DEADLINE ALERT for VNET, MSS, and ASRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, February 26, 2024
Complaint, Register, Suite, Spectrum, Investment, Sale, Risk, EB-5, Law, Supermarket, Facility, Defendant, Security (finance)

LOS ANGELES, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Maison Solutions Inc. (MSS)

Retrieved on: 
Monday, February 26, 2024
Complaint, GPM, Court, Prospectus, International Marxist Group, Register, Suite, News, Hindenburg, IPO, EB-5, WhatsApp, Supermarket, Hindenburg Research, Defendant, Security (finance)

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On December 15, 2023, Hindenburg Research published a report about Maison, alleging a number of “red flags” concerning potentially illegal activities.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Maison Solutions, Assertio, Dada, and Cummins and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, February 26, 2024
Nexus, Complaint, Acquisition, Prospectus, Register, Spectrum, Dada, Marketing, FDA, News, Food, Sale, CMI, Form, Adjustment, Risk, Learning, IPO, Suppository, Rheumatoid arthritis, Spectrum Pharmaceuticals, Patient, ASRT, EPS, P.C, Audit

For more information on the Maison Solutions class action go to: https://bespc.com/cases/MSS

Key Points: 
  • For more information on the Maison Solutions class action go to: https://bespc.com/cases/MSS
    Assertio is a commercial pharmaceutical company that purportedly offers differentiated products to patients utilizing a non-personal promotional model.
  • One of the Company's primary pharmaceutical products is Indocin, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis.
  • According to the complaint, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • For more information on the Cummins class action go to: https://bespc.com/cases/CMI

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Future FinTech, AlloVir, GrafTech, and Instacart and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, February 26, 2024
Complaint, Clinical research associate, Electrode, GrafTech, Reuters, Shareholder, Prospectus, Register, DoorDash, Uber, News, Future, Defendant, Form, Government, Food, IPO, Fintech, Health, Particulates, Sustainable development, Public expenditure, Graphite, Security (finance), EAF, P.C, Environment

For more information on the Future FinTech class action go to: https://bespc.com/cases/FTFT

Key Points: 
  • For more information on the Future FinTech class action go to: https://bespc.com/cases/FTFT
    The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.
  • Specifically, AlloVir said it was discontinuing the posoleucel Phase 3 studies after pre-planned analyses concluded they wouldn’t meet their primary endpoints.
  • On this news, AlloVir’s stock price fell $1.57 per share, or 67.38%, to close at $0.76 per share on December 22, 2023.
  • As of the time the complaint was filed, Instacart's common stock continues to trade below the $30.00 per share Offering price, damaging investors.